MAP2K7

MAP2K7

Gene Overview

<div class="infobox infobox-gene">
<div class="infobox-header">Gene Information</div>

<table>
<tr><th>Symbol</th><td>MAP2K7</td></tr>
<tr><th>Full Name</th><td>Mitogen-Activated Protein Kinase Kinase 7</td></tr>
<tr><th>Alias</th><td>MEK7, MKK7, JNK kinase 2</td></tr>
<tr><th>Chromosome</th><td>19p13.3</td></tr>
<tr><th>NCBI Gene ID</th><td>5609</td></tr>
<tr><th>UniProt ID</th><td>P45985</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000100030</td></tr>
<tr><th>Protein Family</th><td>MAP kinase kinase (MEK) family</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Introduction

MAP2K7 (also known as MEK7 or MKK7) encodes mitogen-activated protein kinase kinase 7, a dual-specificity protein kinase that serves as the primary and most specific activator of the c-Jun N-terminal kinase (JNK) family. The MAP2K7-JNK signaling axis is a central mediator of cellular stress responses and plays critical roles in neuronal survival, synaptic plasticity, neuroinflammation, and neurodegeneration.

MEK7 is distinguished from other MAP2K family members by its unique specificity for JNK activation. Unlike MEK1/2 (which activate ERK1/2) or MEK3/6 (which activate p38 kinases), MEK7 exclusively activates the JNK isoforms (JNK1, JNK2, and JNK3). This specificity makes MAP2K7 a critical regulator of stress-activated signaling in the nervous system.

MAP2K7

Gene Overview

<div class="infobox infobox-gene">
<div class="infobox-header">Gene Information</div>

<table>
<tr><th>Symbol</th><td>MAP2K7</td></tr>
<tr><th>Full Name</th><td>Mitogen-Activated Protein Kinase Kinase 7</td></tr>
<tr><th>Alias</th><td>MEK7, MKK7, JNK kinase 2</td></tr>
<tr><th>Chromosome</th><td>19p13.3</td></tr>
<tr><th>NCBI Gene ID</th><td>5609</td></tr>
<tr><th>UniProt ID</th><td>P45985</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000100030</td></tr>
<tr><th>Protein Family</th><td>MAP kinase kinase (MEK) family</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Introduction

MAP2K7 (also known as MEK7 or MKK7) encodes mitogen-activated protein kinase kinase 7, a dual-specificity protein kinase that serves as the primary and most specific activator of the c-Jun N-terminal kinase (JNK) family. The MAP2K7-JNK signaling axis is a central mediator of cellular stress responses and plays critical roles in neuronal survival, synaptic plasticity, neuroinflammation, and neurodegeneration.

MEK7 is distinguished from other MAP2K family members by its unique specificity for JNK activation. Unlike MEK1/2 (which activate ERK1/2) or MEK3/6 (which activate p38 kinases), MEK7 exclusively activates the JNK isoforms (JNK1, JNK2, and JNK3). This specificity makes MAP2K7 a critical regulator of stress-activated signaling in the nervous system.

The MEK7 protein contains 447 amino acids and possesses a typical kinase domain structure. Alternative splicing generates multiple MEK7 isoforms with distinct expression patterns and regulatory properties. The isoforms differ in their N-terminal regions, which affect their subcellular localization and interaction partners.

The JNK Signaling Pathway

Pathway Architecture

The MAP2K7-JNK cascade is a central stress-activated signaling pathway:[@kuan2002]

Upstream Activation

MAP2K7 is activated by multiple stress signals:[@thompson2023]

• Cellular stress: Oxidative stress, DNA damage, ER stress
• Inflammatory cytokines: TNF-α, IL-1β, Fas ligand
• Excitotoxicity: Glutamate receptor overactivation
• Neurotoxic proteins: Aβ, α-synuclein, mutant huntingtin
• Growth factor withdrawal: Trophic factor deprivation

JNK Isoforms

Three JNK genes encode multiple isoforms:

• JNK1 (MAPK8): Ubiquitously expressed, JNK1a and JNK1b splice variants
• JNK2 (MAPK9): Ubiquitously expressed, multiple isoforms
• JNK3 (MAPK10): Neuron-specific, primarily in brain and heart

Biological Functions in the Nervous System

Neuronal Development

MAP2K7-JNK signaling regulates multiple aspects of brain development:[@gdalyahu2014][@wang2020]

Neuronal Proliferation and Differentiation:

• Controls cell cycle exit in neural progenitors
• Regulates neuronal differentiation programs
• Essential for cortical layering
• Axon guidance and tract formation

• JNK-mediated phosphorylation of MAP1B and SCG10
• Growth cone turning responses
• Axon regeneration capacity
• Cytoskeletal dynamics

Synaptic Plasticity

The MEK7-JNK pathway modulates synaptic function:[@bremner2022][@sahoo2021]

Activity-Dependent Regulation:

• Response to synaptic activity
• AMPA receptor trafficking
• Spine morphogenesis
• LTP and LTD modulation

• c-Jun activation in neurons
• Immediate early gene expression
• Synaptic plasticity-related gene transcription

Stress Response

JNK signaling is central to neuronal stress responses:[@coffey2020]

Cellular Stress:

• Oxidative stress response
• DNA damage signaling
• ER stress response (UPR)
• Mitochondrial stress

• Acute JNK activation: Adaptive, protective
• Chronic JNK activation: Maladaptive, contributes to disease
• Spatial specificity: Distinct pools have different functions

Disease Associations

Alzheimer's Disease

The MEK7-JNK pathway is heavily implicated in AD pathogenesis:[@hernan2020][@jia2022]

Amyloid-Beta Toxicity:

• Aβ activates JNK pathway in neurons
• JNK mediates Aβ-induced synaptic dysfunction
• JNK3 contributes to neuronal vulnerability
• Role in memory deficits

• JNK phosphorylates tau at multiple sites[@zhao2019]
• Activation in NFT-bearing neurons
• Correlation with disease progression
• Interaction with GSK-3β

• JNK-mediated spine loss
• Synaptic protein phosphorylation
• Impaired LTP
• Memory consolidation defects

• JNK in activated microglia
• Cytokine production
• Glial activation

Parkinson's Disease

JNK signaling is a key pathway in PD pathophysiology:[@kim2021]

Dopaminergic Neuron Death:

• JNK activation in substantia nigra
• Response to mitochondrial toxins
• Role in apoptosis
• α-Synuclein toxicity mediation

• Microglial JNK activation
• Pro-inflammatory cytokine production
• Chronic neuroinflammation

• JNK inhibitors in development
• Neuroprotection in models

Amyotrophic Lateral Sclerosis

Motor Neuron Degeneration:

• JNK activation in ALS models
• SOD1-mediated toxicity
• Axonal degeneration[@morlish2022]

Stroke and Brain Injury

The JNK pathway is activated in cerebral ischemia:[@zhang2021]

• Ischemia-reperfusion injury
• Excitotoxicity mediation
• Infarct expansion
• Therapeutic targeting potential

Mechanisms of Neurodegeneration

Apoptosis

JNK signaling promotes neuronal death:[@huang2023]

• Mitochondrial pathway activation
• BIM and other pro-apoptotic proteins
• Caspase activation
• Cytochrome c release

Neuroinflammation

JNK in glial cells drives inflammation:[@xia2019][@lee2020]

Microglial Activation:

• Cytokine production (TNF-α, IL-1β, IL-6)
• Migration and phagocytosis
• NADPH oxidase activation
• Chronic activation state

• Inflammatory mediator release
• Reactive gliosis
• Blood-brain barrier modulation

Synaptic Dysfunction

JNK impairs synaptic communication:

• AMPA receptor internalization
• Presynaptic terminal dysfunction
• Spine loss
• Impaired neurotransmitter release

Axonal Degeneration

JNK mediates axonal injury:[@morlish2022]

• SARM1-independent pathway
• Microtubule disruption
• Energy failure
• Progressive degeneration

Therapeutic Implications

JNK Inhibitors

Multiple JNK-targeted strategies are in development:[@mehan2008][@antoniou2019]

Small Molecule Inhibitors:

• SP600125: Pan-JNK inhibitor
• JNK-IN-8: Potent JNK inhibitor
• CC-930: JNK inhibitor in clinical trials

• Neuroprotection
• Anti-inflammatory effects
• Anti-apoptotic effects

Challenges

• Blood-brain barrier penetration
• Isoform specificity
• Timing of intervention
• Side effects from pathway inhibition

Expression Patterns

Brain Expression

MAP2K7 is expressed throughout the brain:

• High expression: Cerebral cortex, hippocampus, basal ganglia
• Cellular distribution: Neurons, astrocytes, microglia
• Isoform patterns: Different isoforms in different cell types
• Activity regulation: Activation by various stimuli

Developmental Regulation

• Expressed during brain development
• Important for developmental processes
• Altered expression in disease states

Genetic Variants

Known Variants

MAP2K7 genetic variants have been associated with:

• Neurodevelopmental disorders: Some developmental conditions
• Psychiatric disorders: Depression, schizophrenia
• Cancer: Some somatic mutations
• Autoimmune conditions: Immune system disorders

Clinical Significance

• Pharmacogenomics of JNK inhibitors
• Biomarker potential
• Treatment response prediction

Research Directions

Unresolved Questions

Emerging Research

• Optogenetics: Light-controlled JNK activation
• Single-cell analysis: Cell-type specific functions
• Biomarkers: JNK activity as disease biomarker
• Combination therapy: JNK inhibition with other targets

Protein Structure and Function

Structural Features

The MEK7 protein contains several key structural features:

Kinase Domain:

• Dual-specificity protein kinase domain
• Activation loop with phosphorylation sites (S272, T276)
• DFG motif for ATP binding
• Substrate docking domain

• MEK7α1/α2: Different N-terminal variants
• MEK7β: Alternative splice form
• Isoform-specific localization and function

Catalytic Mechanism

MEK7 phosphorylates JNK through:

Protein Interactions

MEK7 interacts with:

• MAPKKK: MEKK1-4, MLK, TAK1
• JNK: Primary substrate
• Scaffold proteins: JIP proteins for pathway assembly
• Phosphatases: MKP1, MKP7 for pathway termination

Animal Models

Knockout Studies

MAP2K7 and JNK knockout mice:

MEK7 Knockout:

• Embryonic lethal in most lines
• Tissue-specific knockouts reveal specific functions
• Neuron-specific deletion: Altered stress responses

• JNK1-/-, JNK2-/-: Viable, altered stress responses
• JNK3-/-: Protected from neuronal death
• Double knockouts: Enhanced phenotypes

Transgenic Models

JNK Transgenic:

• Neuronal JNK1 overexpression: Enhanced neurodegeneration
• JNK3 conditional: Disease model applications

• D-JNKI1: Cell-permeable JNK inhibitor
• Peptide inhibitors: Target-based delivery

Behavioral Studies

Learning and Memory:

• JNK inhibition: Enhanced memory
• JNK3 knockouts: Altered plasticity

• Basal ganglia JNK in movement
• Dopaminergic neuron sensitivity

• JNK in stress responses
• Depression-related behaviors

Signaling Pathway Integration

Cross-talk with Other Pathways

ERK Pathway:

• Opposing functions in survival vs death
• Shared transcription factor targets
• Coordinated cellular responses

• Common stress-activated upstream
• Complementary functions
• Parallel cellular outcomes

Integration with Other Signaling

cAMP/PKA:

• Modulation of JNK activity
• Cross-talk at transcription factors

• Activity-dependent JNK activation
• Calmodulin interactions

• Parallel inflammatory signaling
• Coordinated responses

Spatial Signaling

Nuclear JNK:

• Transcriptional regulation
• c-Jun phosphorylation
• Gene expression programs

• Cytoskeletal effects
• Mitochondrial effects
• Local signaling

• Synaptic plasticity modulation
• Spine-specific functions

Clinical Perspectives

Biomarker Development

JNK activity as clinical biomarker:

Diagnostic Applications:

• Disease state identification
• Subtype classification
• Early detection

• Outcome prediction
• Progression monitoring
• Treatment response

• Target engagement
• Pathway modulation
• Efficacy measures

Therapeutic Strategies

Direct JNK Inhibitors:

• SP600125, JNK-IN-8
• CC-930 in clinical trials
• Brain-penetrant compounds

• Upstream kinase inhibitors
• Transcription factor targets
• Downstream effectors

• With neuroprotective agents
• With anti-inflammatory drugs
• With disease-modifying therapies

Clinical Development

• Phase I/II trials for neurological disorders
• BBB-penetrant JNK inhibitors
• Biomarker-driven patient selection
• Combination trial designs

Biochemical Properties

Enzyme Kinetics

Substrate Specificity:

• High specificity for JNK isoforms
• Different Km for JNK1/2/3
• Vmax varies by isoform

• Dual phosphorylation on T183/Y185
• D-domain mediated interactions
• Phosphatase-mediated termination

Post-Translational Modifications

Phosphorylation:

• T183 and Y185: Activation loop
• Additional regulatory sites
• Autophosphorylation

• Ubiquitination: Degradation
• Acetylation: Activity modulation
• Sumoylation: Localization

Protein Complexes

MEK7 in signaling complexes:

With JNK:

• JIP scaffold complexes
• MAPK module assemblies
• Nuclear-cytoplasmic shuttling

• Upstream MAPKKK
• Phosphatases
• Substrate proteins

Disease Mechanisms

Neurodegeneration Initiation

JNK in disease onset:

Early Events:

• Stress signal activation
• Synaptic dysfunction onset
• Initial cell stress responses

• Chronic JNK activation
• Inflammatory amplification
• Apoptosis execution

Neuronal Vulnerability

Factors affecting sensitivity:

• High JNK3 expression in neurons
• Limited JNK phosphatase activity
• Excitability-driven stress

Models and Systems

In Vitro Models

Cell culture for JNK studies:

Primary Cells:

• Cortical neurons: Death mechanisms
• Hippocampal neurons: Synaptic effects
• Dopaminergic neurons: PD models

• HT-22: Oxidative stress
• SH-SY5Y: Differentiation
• NSC-34: ALS models

In Vivo Models

Animal models:

Knockout Mice:

• JNK1-/-: Viable
• JNK2-/-: Viable
• JNK3-/-: Protected neurons

• JNK1/2 overexpression
• Dominant-negative JNK
• Reporter mice

Measurement Methods

Activity Detection

Kinase Assays:

• In vitro phosphorylation
• Immunoprecipitation
• Activity-based probes

• Phospho-JNK T183/Y185
• Phospho-c-Jun S63
• Pathway-specific detection

Expression Analysis

mRNA:

• qRT-PCR
• RNAseq
• In situ hybridization

• Western blot
• IHC
• ELISA

Therapeutic Considerations

Target Selection

Rationale for JNK targeting:

• Central role in neuronal death
• Accessible activation loop
• Isoform-specific potential

Development Challenges

Chemistry:

• Selectivity over other MAPKs
• Brain penetration
• Compound stability

• Acute vs chronic timing
• Isoform-specific effects
• Compensation mechanisms

Clinical Applications

Potential uses:

• Acute neuroprotection
• Chronic disease modification
• Combination therapy

See Also

• [JNK Signaling Pathway](/mechanisms/jnk-signaling-pathway)
• [MAPK Signaling in Neurodegeneration](/mechanisms/mapk-signaling-neurodegeneration)
• [Apoptosis Pathways in Neurodegeneration](/mechanisms/apoptosis-neurodegeneration)
• [Neuroinflammation Mechanisms](/mechanisms/neuroinflammation-mechanisms)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Stroke and Brain Injury](/mechanisms/stroke-pathophysiology)

References

External Links

• [NCBI Gene - MAP2K7](https://www.ncbi.nlm.nih.gov/gene/5609)
• [UniProt - P45985](https://www.uniprot.org/uniprot/P45985)
• [Ensembl - ENSG00000100030](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000100030)
• [KEGG Pathway - MAPK signaling](https://www.genome.jp/kegg/pathway/map04010.html)
• [KEGG Pathway - JNK signaling](https://www.genome.jp/kegg/pathway/map04016.html)
• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)